November 2022
Workers told to stay home as COVID-19 ‘variant soup’ drives wave
At least 79,700 people contracted coronavirus in the seven days to last Thursday, more than double the 33,600 weekly infections recorded in the final week of October.
- Michael Read
COVID-19 wave to ‘peak soon and drop quickly’
The nation’s top doctor says the latest wave is near its peak and cases should drop sharply soon after, despite a near-50 per cent increase in infections.
- Michael Read
Six things to know about the new XBB COVID variant
Singapore has been living with the highly infectious, immune evasive strain for months – and now it’s taking off in Australia.
- Emma Connors
August 2022
After 2240pc run, Tesla visionary leaves a precarious legacy
The tech stock meltdown has left Scottish investment manager Baillie Gifford bleeding assets this year, losing a staggering $170 billion by the end of June.
- Loukia Gyftopoulou
Britain the first to approve dual omicron-delta vaccine
Moderna’s bivalent shot, which targets the original strain and the omicron variant, gives the country a “sharpened tool” against the virus.
- Natalie Grover
July 2022
Australia facing ‘fierce competition’ to buy children’s vaccine
Health Minister Mark Butler says Australia is yet to secure supply of Moderna’s new vaccine for young children, which received provisional approval on Tuesday.
- Updated
- Michael Read
June 2022
Jane Halton tapped to lead COVID-19 vaccine review
Health Minister Mark Butler said he expects advice on vaccine supply arrangements within weeks
- Tom McIlroy
COVID-19 vaccines saved 20m lives in first year: study
The study is the first of its kind to quantify the pandemic’s deadly impact. It analysed records and total excess mortality from each country.
- James Paton
Children under five could get COVID jabs within weeks
Health Minister Mark Butler said the Albanese government would likely hold a royal commission of inquiry into the COVID-19 pandemic response
- Tom McIlroy
March 2022
Moderna partners with UQ to develop new-age vaccines
The University of Queensland will partner with biotechnology giant Moderna to create vaccines to tackle the world’s greatest global public health threats.
- Julie Hare
February 2022
Health experts hope Novavax will sway vaccine hold-outs
Health experts hope the availability of the protein-based vaccine will push Australia’s world-leading vaccination rate even higher.
- Michael Read
January 2022
- Opinion
- Pharmaceuticals
It’s time to make our own supply of lifesaving drugs
Australia has already done the hard yards on research and development - now we just need the policies to create a manufacturing powerhouse.
- Chris Nave
December 2021
How a simple investment process led to Facebook, Moderna
Axiom Investors’ Bradley Amoils employs a clever process that has allowed the fund manager to find some early gems.
- William McInnes
The corporate winners in Australia’s COVID-19 spending splurge
The Health Department estimates total COVID-19 costs at more than $32.6 billion, including $8 billion for vaccines
- Tom McIlroy
Boosters ‘massively increase’ protection against omicron
Researchers working in an ultra-secure lab have compiled the first data on the effectiveness of vaccines against the omicron variant.
- Tom McIlroy
Moderna’s Melbourne move predicted to spark medical R&D boom
Victoria was chosen for its strong record in medical research and vaccine development.
- Tom McIlroy